BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12199779)

  • 1. Molecular characterization of a new recombination of the SIL/TAL-1 locus in a child with T-cell acute lymphoblastic leukaemia.
    Carlotti E; Pettenella F; Amaru R; Slater S; Lister TA; Barbui T; Basso G; Cazzaniga G; Rambaldi A; Biondi A
    Br J Haematol; 2002 Sep; 118(4):1011-8. PubMed ID: 12199779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RT/PCR detection of SIL-TAL-1 fusion mRNA in Chinese T-cell acute lymphoblastic leukemia (T-ALL).
    Huang W; Kuang SQ; Huang QH; Dong S; Zhang T; Gu LJ; Ching LM; Chen SJ; Chang LC; Chen Z
    Cancer Genet Cytogenet; 1995 May; 81(1):76-82. PubMed ID: 7773964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genes.
    Breit TM; Mol EJ; Wolvers-Tettero IL; Ludwig WD; van Wering ER; van Dongen JJ
    J Exp Med; 1993 Apr; 177(4):965-77. PubMed ID: 8459224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of SIL-TAL1 fusion gene transcripts associated with human T-cell lymphocytic leukemia by real-time reverse transcriptase-PCR.
    Curry JD; Smith MT
    Leuk Res; 2003 Jul; 27(7):575-82. PubMed ID: 12681356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A third tal-1 promoter is specifically used in human T cell leukemias.
    Bernard O; Azogui O; Lecointe N; Mugneret F; Berger R; Larsen CJ; Mathieu-Mahul D
    J Exp Med; 1992 Oct; 176(4):919-25. PubMed ID: 1402666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. tal-1 deletions in T-cell acute lymphoblastic leukemia as PCR target for detection of minimal residual disease.
    Breit TM; Beishuizen A; Ludwig WD; Mol EJ; Adriaansen HJ; van Wering ER; van Dongen JJ
    Leukemia; 1993 Dec; 7(12):2004-11. PubMed ID: 8255100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TAL1 expression does not occur in the majority of T-ALL blasts.
    Delabesse E; Bernard M; Meyer V; Smit L; Pulford K; Cayuela JM; Ritz J; Bourquelot P; Strominger JL; Valensi F; Macintyre EA
    Br J Haematol; 1998 Jul; 102(2):449-57. PubMed ID: 9695959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous SIL-TAL1 RT-PCR detection of all tal(d) deletions and identification of novel tal(d) variants.
    Delabesse E; Bernard M; Landman-Parker J; Davi F; Leboeuf D; Varet B; Valensi F; Macintyre EA
    Br J Haematol; 1997 Dec; 99(4):901-7. PubMed ID: 9432040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent clonal loss of heterozygosity (LOH) in the chromosomal region 1p32 occurs in childhood T cell acute lymphoblastic leukemia (T-ALL) carrying rearrangements of the TAL1 gene.
    Iolascon A; Faienza MF; Coppola B; Moretti A; Basso G; Amaru R; ViganĂ² G; Biondi A
    Leukemia; 1997 Mar; 11(3):359-63. PubMed ID: 9067574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-tal, a helix-loop-helix protein, is juxtaposed to the T-cell receptor-beta chain gene by a reciprocal chromosomal translocation: t(1;7)(p32;q35).
    Fitzgerald TJ; Neale GA; Raimondi SC; Goorha RM
    Blood; 1991 Nov; 78(10):2686-95. PubMed ID: 1824262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the V(D)J recombination efficiency at lymphoid chromosomal translocation breakpoints.
    Raghavan SC; Kirsch IR; Lieber MR
    J Biol Chem; 2001 Aug; 276(31):29126-33. PubMed ID: 11390401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell acute lymphoblastic leukemia--the associated gene SCL/tal codes for a 42-Kd nuclear phosphoprotein.
    Goldfarb AN; Goueli S; Mickelson D; Greenberg JM
    Blood; 1992 Dec; 80(11):2858-66. PubMed ID: 1450410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIL/TAL1 recombination in adult T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma.
    Kwong YL; Chan D; Liang R
    Cancer Genet Cytogenet; 1995 Dec; 85(2):159-60. PubMed ID: 8548743
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of anti-tal-1 oligodeoxynucleotides in T-ALL cell lines.
    Anderegg B; Horstmann M; Kabisch H
    Cancer Gene Ther; 1997; 4(2):84-90. PubMed ID: 9080116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia.
    Aplan PD; Lombardi DP; Reaman GH; Sather HN; Hammond GD; Kirsch IR
    Blood; 1992 Mar; 79(5):1327-33. PubMed ID: 1311214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of tal-1 and GATA-binding proteins during human hematopoiesis.
    Mouthon MA; Bernard O; Mitjavila MT; Romeo PH; Vainchenker W; Mathieu-Mahul D
    Blood; 1993 Feb; 81(3):647-55. PubMed ID: 7678994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single split-signal FISH probe set allows detection of TAL1 translocations as well as SIL-TAL1 fusion genes in a single test.
    van der Burg M; Smit B; Brinkhof B; Barendregt BH; Verschuren MC; Dib M; Beverloo HB; van Dongen JJ; Langerak AW
    Leukemia; 2002 Apr; 16(4):755-61. PubMed ID: 11960364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIL-TAL1 deletion in T-cell acute lymphoblastic leukemia.
    Janssen JW; Ludwig WD; Sterry W; Bartram CR
    Leukemia; 1993 Aug; 7(8):1204-10. PubMed ID: 8350619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCL/Tal-1 expression in T-acute lymphoblastic leukemia: an immunohistochemical and genotypic study.
    Chetty R; Pulford K; Jones M; Mathieu-Mahul D; Close P; Hussein S; Pallesen G; Ralfkiaer E; Stein H; Gatter K
    Hum Pathol; 1995 Sep; 26(9):994-8. PubMed ID: 7672800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural characterization of SIL, a gene frequently disrupted in T-cell acute lymphoblastic leukemia.
    Aplan PD; Lombardi DP; Kirsch IR
    Mol Cell Biol; 1991 Nov; 11(11):5462-9. PubMed ID: 1922059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.